• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Vaccines, Blood & Biologics

  • Print
  • Share
  • E-mail

Info Request PNR Issue - July 21, 2009

From:                     Lewis, Kelly R

Sent:                      Tuesday, July 21, 2009 3:38 PM

To:                         'Smith, Howard'

Subject:                 BLA STN 125329/0 tradename

Hi Howard,

Here is an information request question regarding the tradename:

"Please justify your tradename "Gammaplex" by providing information on any other drug/biologic having the suffix "-plex". We note that there is a potential confusion leading people to believe the product to be among the Prothrombin Complex Concentrates (PCCs), such as Autoplex T, Beriplex P/N or Octaplex."

Please respond as soon as possible.

Thank you,

Kelly

 

Kelly Lewis
Regulatory Project Manager
Division of Blood Applications
FDA/CBER/OBRR
HFM-380
Phone: 301 827 9427
Fax: 301 827 2858
email: kelly.lewis@fda.hhs.gov

 

"THIS MESSAGE IS INTENDED ONLY FOR THE USE OF THE PARTY TO WHOM IT IS ADDRESSED AND MAY CONTAIN INFORMATION THAT IS PRIVILEGED, CONFIDENTIAL, AND PROTECTED FROM DISCLOSURE UNDER LAW. If you are not the addressee, or a person authorized to deliver the document to the addressee, you are hereby notified that any review, disclosure, dissemination, copying, or other action based on the content of this communication is not authorized. If you have received this document in error, please immediately notify the sender immediately by e-mail or phone."